Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Thermo Fisher Scientific Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021 Dec 31, 2020 Sep 26, 2020 Jun 27, 2020 Mar 28, 2020
Short-term obligations and current maturities of long-term obligations
Accounts payable
Accrued payroll and employee benefits
Contract liabilities
Other accrued expenses
Current liabilities
Deferred income taxes
Other long-term liabilities
Long-term obligations, excluding current maturities
Long-term liabilities
Total liabilities
Redeemable noncontrolling interest
Preferred stock, $100 par value; none issued
Common stock, $1 par value
Capital in excess of par value
Retained earnings
Treasury stock at cost
Accumulated other comprehensive loss
Total Thermo Fisher Scientific Inc. shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities, redeemable noncontrolling interest and equity

Based on: 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-02), 10-Q (reporting date: 2021-07-03), 10-Q (reporting date: 2021-04-03), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-26), 10-Q (reporting date: 2020-06-27), 10-Q (reporting date: 2020-03-28).


Short-term obligations and current maturities of long-term obligations
This category exhibited a fluctuating pattern over the observed periods, starting at 1.26% in March 2020, dipping to nearly zero mid-2020, then rising significantly to a peak of 6.47% in July 2023, followed by a general decreasing trend to 2.85% by March 2025. This indicates variability in the proportion of short-term debt relative to total liabilities and equity, with notable increases in late 2022 and mid-2023.
Accounts payable
The proportion remained relatively stable around the 2.5% to 3.2% range throughout the periods, with minor fluctuations but no clear long-term upward or downward trend. This consistency suggests stable management of payable obligations relative to the company’s total financing structure.
Accrued payroll and employee benefits
This item showed initial growth from 1.29% to a peak of 2.77% by the end of 2020, followed by a decline to about 1.38% in early 2023 before increasing again to around 2.04% by July 2024 and then declining slightly toward 1.43% by March 2025. The variation likely mirrors changes in payroll liabilities as a portion of total financing.
Contract liabilities
An overall increasing trend was observed from 1.6% in early 2020 to a peak of approximately 3.1% in early 2022, followed by a slight decline and stabilization around the 2.6% to 2.9% range in recent quarters. This suggests growth in deferred revenue or prepayments relative to total liabilities and equity, with moderation in the later periods.
Other accrued expenses
The category maintained a generally stable range between 2.5% and 3.5%, with minor peak variations, highlighting consistent accrual management within total financing components.
Current liabilities
Significant volatility was evident in current liabilities as a percentage of total financing, with a jump from around 9% in early 2020 to peaks exceeding 17.5% in December 2022. Subsequently, a slight decline and stabilization occurred, settling near 13% to 16% in recent quarters, indicating fluctuating short-term financial obligations and possible impact from operational or strategic financing adjustments.
Deferred income taxes
This category declined over time from 3.64% in early 2020 to near 1.05% by March 2025, reflecting a consistent reduction in deferred tax liabilities relative to total liabilities and equity.
Other long-term liabilities
Relatively stable within the 4% to 5.5% range, these liabilities showed minor fluctuations but no directional trend, suggesting steady non-current liabilities components aside from long-term obligations.
Long-term obligations, excluding current maturities
This item fluctuated moderately, starting at 32.77% and falling to as low as 27.67% in December 2020, followed by recovery and oscillation around 30% to 33%. This indicates shifts in long-term debt holdings relative to total financing with some episodic declines and recoveries.
Long-term liabilities
Long-term liabilities displayed a descending peak-to-trough pattern from about 42% down to 35%, then partially rebounding to near 38%, reflecting adjustments in long-term financial obligations within the capital structure over the period under review.
Total liabilities
The total liabilities percentage relative to total financing decreased from just over 51% early in 2020 to under 49% by early 2025, with intermediate peaks around 56.9% in late 2021. This trend indicates a gradual reduction in reliance on liabilities for financing, despite temporary increases.
Redeemable noncontrolling interest
Where reported, this component remained marginal around 0.12% to 0.13%, suggesting minimal influence on the overall financial structure.
Common stock and capital in excess of par value
Common stock proportion stayed roughly constant around 0.44% to 0.74%, with a slight decline over the time series. Capital in excess of par value demonstrated an initial decline from near 26% to approximately 17%, then hovered slightly below 19% thereafter, indicating equity structure adjustments possibly related to share issuance or buybacks.
Retained earnings
Retained earnings showed a clear upward trend, rising from approximately 39% in early 2020 to about 55% by early 2025, reflecting consistent accumulation of earnings and reinvestment retained within shareholders' equity.
Treasury stock at cost
This item increased in absolute negative value from about -9.87% in late 2020 to -21.47% by early 2025. The growing negative percentage indicates increasing share repurchases and treasury stock accumulation, which reduces total shareholders' equity proportionately.
Accumulated other comprehensive loss
This component remained negative throughout, ranging from about -5.26% to near -2.37%, with a general trend toward reduced comprehensive losses over time, indicating improved other comprehensive income components relative to total financing.
Total shareholders' equity
Total equity showed volatility, peaking above 54% mid-2021 and later dipping to about 42.9% around late 2021 before gradually increasing again to roughly 51% by early 2025. The fluctuations correspond with changes in retained earnings, treasury stock, and other equity components, suggesting dynamic equity management and capital adjustments.
Noncontrolling interests
Where reported, this category remained close to zero with minor negative values appearing in late periods, indicating very limited impact on the equity base.
Total liabilities, redeemable noncontrolling interest and equity
By definition, this aggregates to 100% at each period, providing a balanced view of financing sources.